Regulators OK lung cancer screening for Medicare beneficiaries ... Anthem hackers suspected to have accessed personal information, including Social Security numbers ...15% of meaningful use Stage 2-eligible professionals have attested to the program's requirements, ONC says
The U.S. Food and Drug Administration has given premarket approval to the cobas® EGFR Mutation Test from Roche Molecular Systems, creating a possible future option for metastatic lung cancer patients.
Contrary to what some observers believe, a new study concludes that chronic obstructive pulmonary disease (COPD) is not an independent risk factor for lung cancer.
Researchers are developing a breathalyzer that may soon be able to detect diabetes, lung cancer, viral infections and other maladies that often affect nursing home patients. Patients blow into a small valve attached to a box that is about half the size of a typical shoebox and weighs less than one pound. The device then seeks biomarkers for conditions and ailments. Funding for the project has been provided by the National Science Foundation.